Playback speed
×
Share post
Share post at current time
0:00
/
0:00
Transcript
27

How many vaccinated deaths is too many?

Reflections on the Pandemic: A Call for Broader Solutions
27

I want to address a pressing concern—the significant number of unnecessary deaths during the pandemic, particularly within the vaccinated population. This issue has been highlighted by a recent study showing clear benefits of vaccination for high-risk older males, especially before the emergence of variants like Omicron and Delta. However, I believe we could have done more.

Dr McMillan Health & Wellness: McMillan and Members Session 1
Thursday August 22, 2024 at 7PM UK time

Register Here >

The study confirms that vaccination significantly reduced mortality in this group, but I’m concerned that the medical community placed too much focus on vaccination, neglecting other potential treatments. Throughout the pandemic, I’ve spoken with clinicians worldwide who achieved outstanding results (for example - Dr Shankara Chetty, South Africa) using simple, early interventions. This raises an important question: Did we miss the opportunity to explore additional strategies that could have saved more lives?

Xie, Yan, Taeyoung Choi, and Ziyad Al-Aly. "Postacute sequelae of SARS-CoV-2 infection in the pre-delta, delta, and omicron eras." New England Journal of Medicine (2024).

My concern has always been about the nuances—acknowledging that treatments can offer both benefits and risks. I’ve long advocated for targeted vaccination, and I believe the data now supports this approach. However, the narrative often oversimplified the role of vaccines, suggesting they were the only solution. In reality, we needed a more comprehensive strategy.


I’m also launching a Kickstarter program titled "Are You Prepared for Disease X?"—a project aimed at preparing for future health crises. By joining, you’ll receive a FREE promotional ebook that highlights key discussions with medical experts.

FREE - Capitol COVID-19 Conversations


In summary, while targeted vaccination was beneficial for high-risk groups, we should have explored more options to optimize outcomes. As we move forward, it’s crucial to continue asking tough questions, challenging narratives, and seeking the best possible solutions for our health.

Thank you for being part of this journey.

Please support my research efforts by subscribing to Vejon Health Substack. Your support allows me to continue bringing you my insights in a timely and effective way.

Discussion about this podcast

Vejon COVID-19 Review
Vejon COVID-19 Review Podcast
Comprehensive overview of COVID-19 looking at the research from Dr Philip McMillan delineating autoimmunity in the disease.